Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Bard to distribute ProCyte's wound care products

Dec. 17, 1997

Gliatech's ADCON-L recommended for approval

Dec. 15, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

Preclinical profile of Novartis' dermatology candidate

Dec. 9, 1997

Promising results reported from pilot trial of Repel

Dec. 9, 1997

New melanogenesis inhibitor isolated from actinomycete

Dec. 1, 1997

Novel retinoids from Roche

Dec. 1, 1997

MedImmune seeks FDA approval for psoriasis trials with MEDI-507

Nov. 28, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

New histamine antagonists described for dermatological indications

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...